GlucoTrack (GCTK) elects Victoria Carr-Brendel to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28, 2025 8:30 AM EDTExperienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology
RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Victoria E. Carr-Brendel, PhD, was elected to the Companys Board of Directors, effective May 22, 2025.
We are delighted to welcome Dr. Carr-Brendel to Glucotracks Board of Directors, said Paul V. Goode, PhD, President and Chief... More
